-
-
-
-
-
-
-
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
-
-
-
-
-
-
-
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
-
-
-
-
-
-
-
Sarepta Therapeutics gains as Pfizer failure removes overhang
-
-
-
-
-
-
-
TIVDAK® Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer
-
-
-
-
-
-
-
Pfizer Reports Second-Quarter 2023 Results
-
-
-
-
-
-
-
Pfizer Reports First-Quarter 2023 Results
-
-
-
-
-
-
-
Pfizer (PFE) Announces FDA Acceptance of Application for Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review
-
15,434 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

